Market Dynamics
Drivers - The advances in technology is one of the key driver supporting the atrial fibrillation surgery market growth. The technology offers high-resolution imagining of the heart tissues. This allows surgeons to pinpoint the exact location of the arrhythmia, improving the effectiveness of the procedure. The implementation of these types of devices will help surgeons reduce human errors and improve the quality of treatment. Surgeons can also use cryoablation, laser, and cryo energy-based ablation instead of RF-based ablation to treat individuals with arrhythmias. This will lead to the demand and use of sophisticated and advanced technologies-based ablation catheters. Such increasing demand will drive market growth during the forecast period.
Challenges -The high cost of ablation catheters is one of the factors hindering the atrial fibrillation surgery market growth. The use of catheter ablation for treating arrhythmias has led to the demand for advanced devices that can help improve the safety and effectiveness of associated procedures. However, most of these devices enabled with technologies such as 3D mapping, and remote catheter navigation are expensive. This deters individuals, particularly in developing countries, from undergoing catheter ablation procedures. Moreover, most hospitals and surgical centers worldwide perform less than 100 catheter ablation procedures per year, limiting the need for these high-end devices. Many countries such as the US, the UK, and Germany are shifting toward value-based purchasing to focus on the use of efficient devices and decrease the expenditure on medical facilities. Such challenges are limiting the market growth.
To know more about drivers, challenges along upcoming trends - Download a free sample now!
Company Profiles
The atrial fibrillation surgery market is fragmented and the vendors are deploying growth strategies such as product launches and business expansions to compete in the market. The atrial fibrillation surgery market report includes information on the product launches, sustainability, and prospects of leading vendors including Abbott Laboratories, AtriCure Inc., BIOTRONIK SE, and Co KG, Boston Scientific Corp., CardioFocus Inc., General Electric Co., Johnson and Johnson, Medtronic Plc, Koninklijke Philips NV, Siemens Healthineers AG, MicroPort Scientific Corp., Boehringer Ingelheim International GmbH, Stereotaxis Inc, Tempus Labs Inc., Teleflex Inc., Lepu Medical Technology Beijing Co. Ltd., AngioDynamics Inc., Avanos Medical Inc., and OSYPKA AG. The product offerings for one of the companies include -
- Abbott Laboratories - The company offers flexAbility ablation catheter and sensor-enabled which is designed to facilitate detailed, accurate model creation and effective lesion creation and to yield safe, effective outcomes for patients.
- To know about all major vendors with their key offerings - Download a free sample now!
Competitive Analysis
The competitive scenario provided in the atrial fibrillation surgery market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
Market Segmentation Analysis
- By Product, the market is classified as catheter ablation and surgical ablation. The atrial fibrillation surgery market share growth by the catheter ablation segment will be significant during the forecast period. Catheter ablation is a procedure that destroys specific regions of the heart that cause cardiac rhythm issues. Catheters are thin, flexible wires that are threaded up the vein to the heart. Each catheter's electrode releases radio waves that cause heat, which destroys the heart tissues that cause a higher heart rate or cardiac arrhythmia. Arrhythmias can strike anyone at any age, but they are more common in the elderly. The operation can be done with prior electrophysiology (EP) testing, which allows clinicians to pinpoint the exact heart tissues having aberrant electrical pathways. When persons have persistently high heart rates and are resistant to pharmacological therapy, cardiac ablation catheters are frequently employed. Such applications are driving the segment growth.
- By Geography, the market is classified as North America, Europe, Asia, and the Rest of the World (ROW). North America will have the largest share of the market. 37% of the market's growth will originate from North America during the forecast period. The US is the key market for atrial fibrillation surgery market in North America. Market growth in this region will be faster than the growth of the market in ROW. The rising prevalence of obesity will facilitate the atrial fibrillation surgery market growth in North America over the forecast period.
To know about the market contribution of each segment - Download a free sample now!
Related Reports
- The infusion systems market share is expected to increase by USD 1.84 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.22%. Download a free sample now!
- The bone biopsy market share is expected to increase by USD 45.03 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.81%. Download a free sample now!
Atrial Fibrillation Surgery Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 14.17% |
Market growth 2022-2026 |
USD 1.89 billion |
Market structure |
Fragmented |
YoY growth (%) |
13.54 |
Performing market contribution |
North America at 37% |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, AtriCure Inc., BIOTRONIK SE and Co KG, Boston Scientific Corp., CardioFocus Inc., General Electric Co., Johnson and Johnson, Medtronic Plc, Koninklijke Philips NV, Siemens Healthineers AG, MicroPort Scientific Corp., Boehringer Ingelheim International GmbH, Stereotaxis Inc, Tempus Labs Inc., Teleflex Inc., Lepu Medical Technology Beijing Co. Ltd., AngioDynamics Inc., Avanos Medical Inc., and OSYPKA AG |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Content
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
- 5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
- 5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product
- 5.3 Catheter ablation - Market size and forecast 2021-2026
- Exhibit 28: Chart on Catheter ablation - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Catheter ablation - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Catheter ablation - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Catheter ablation - Year-over-year growth 2021-2026 (%)
- 5.4 Surgical ablation - Market size and forecast 2021-2026
- Exhibit 32: Chart on Surgical ablation - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Surgical ablation - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Surgical ablation - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Surgical ablation - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Product
- Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 China - Market size and forecast 2021-2026
- Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 Germany - Market size and forecast 2021-2026
- Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.11 Japan - Market size and forecast 2021-2026
- Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 85: Abbott Laboratories - Overview
- Exhibit 86: Abbott Laboratories - Business segments
- Exhibit 87: Abbott Laboratories - Key news
- Exhibit 88: Abbott Laboratories - Key offerings
- Exhibit 89: Abbott Laboratories - Segment focus
- 10.4 AtriCure Inc.
- Exhibit 90: AtriCure Inc. - Overview
- Exhibit 91: AtriCure Inc. - Product / Service
- Exhibit 92: AtriCure Inc. - Key offerings
- 10.5 BIOTRONIK SE and Co KG
- Exhibit 93: BIOTRONIK SE and Co KG - Overview
- Exhibit 94: BIOTRONIK SE and Co KG - Product / Service
- Exhibit 95: BIOTRONIK SE and Co KG - Key offerings
- 10.6 Boston Scientific Corp.
- Exhibit 96: Boston Scientific Corp. - Overview
- Exhibit 97: Boston Scientific Corp. - Business segments
- Exhibit 98: Boston Scientific Corp. - Key news
- Exhibit 99: Boston Scientific Corp. - Key offerings
- Exhibit 100: Boston Scientific Corp. - Segment focus
- 10.7 CardioFocus Inc.
- Exhibit 101: CardioFocus Inc. - Overview
- Exhibit 102: CardioFocus Inc. - Product / Service
- Exhibit 103: CardioFocus Inc. - Key offerings
- 10.8 General Electric Co.
- Exhibit 104: General Electric Co. - Overview
- Exhibit 105: General Electric Co. - Business segments
- Exhibit 106: General Electric Co. - Key news
- Exhibit 107: General Electric Co. - Key offerings
- Exhibit 108: General Electric Co. - Segment focus
- 10.9 Johnson and Johnson
- Exhibit 109: Johnson and Johnson - Overview
- Exhibit 110: Johnson and Johnson - Business segments
- Exhibit 111: Johnson and Johnson - Key news
- Exhibit 112: Johnson and Johnson - Key offerings
- Exhibit 113: Johnson and Johnson - Segment focus
- 10.10 Koninklijke Philips NV
- Exhibit 114: Koninklijke Philips NV - Overview
- Exhibit 115: Koninklijke Philips NV - Business segments
- Exhibit 116: Koninklijke Philips NV - Key news
- Exhibit 117: Koninklijke Philips NV - Key offerings
- Exhibit 118: Koninklijke Philips NV - Segment focus
- 10.11 Medtronic Plc
- Exhibit 119: Medtronic Plc - Overview
- Exhibit 120: Medtronic Plc - Business segments
- Exhibit 121: Medtronic Plc - Key news
- Exhibit 122: Medtronic Plc - Key offerings
- Exhibit 123: Medtronic Plc - Segment focus
- 10.12 Siemens Healthineers AG
- Exhibit 124: Siemens Healthineers AG - Overview
- Exhibit 125: Siemens Healthineers AG - Business segments
- Exhibit 126: Siemens Healthineers AG - Key news
- Exhibit 127: Siemens Healthineers AG - Key offerings
- Exhibit 128: Siemens Healthineers AG - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources
- 11.5 List of abbreviations
- Exhibit 135: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article